ERBB2 and cancer: Cancer with bone metastasis showed estrogen receptor and SNAI1 over-expression; cancer with liver metastasis showed SNAI1 over-expression; and cancer with lung metastasis showed EGFR, CK5 and HER2 protein over-expression (Sihto et al., 2011).